15
views
0
recommends
+1 Recommend
2 collections
    0
    shares

          The flagship journal of the Society for Endocrinology. Learn more

      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Tumour diameter is not reliable for management of non-secreting pancreatic neuroendocrine tumours

      research-article

      Read this article at

      ScienceOpenPublisherPMC
          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Small non-functioning pancreatic NETs (pNETs) ≤2 cm can pose a management dilemma in terms of surveillance or resection. There is evidence to suggest that a surveillance approach can be considered since there are no significant radiological changes observed in lesions during long-term follow-up. However, other studies have suggested loco-regional spread can be present in ≤2 cm pNETs. The aim of this study was to characterise the prevalence of malignant features and identify any useful predictive variables in a surgically resected cohort of pNETs. 418 patients with pNETs were identified from 5 NET centres. Of these 227 were included for main analysis of tumour characteristics. Mean age of patients was 57 years, 47% were female. The median follow-up was 48.2 months. Malignant features were identified in 38% of ≤2 cm pNETs. ROC analysis showed that the current cut-off of 20 mm had a sensitivity of 84% for malignancy. The rate of malignant features is in keeping with other surgical series and challenges the belief that small pNETs have a low malignant potential. This study does not support a 20 mm size cut-off as being a solitary safe parameter to exclude malignancy in pNETs.

          Related collections

          Most cited references19

          • Record: found
          • Abstract: found
          • Article: found

          ENETS Consensus Guidelines Update for the Management of Patients with Functional Pancreatic Neuroendocrine Tumors and Non-Functional Pancreatic Neuroendocrine Tumors

            • Record: found
            • Abstract: found
            • Article: not found

            Small, nonfunctioning, asymptomatic pancreatic neuroendocrine tumors (PNETs): role for nonoperative management.

            Controversy exists regarding the optimal management of incidentally discovered, small pancreatic neuroendocrine tumors (PNETs). Our aim was to review the outcomes of patients who underwent nonoperative and operative management. We retrospectively reviewed patients with nonfunctioning PNETs at our institution from January 1, 2000 to June 30, 2011. Patients were included if the tumor was sporadic and <4 cm without radiographic evidence of local invasion or metastases. Nonoperative patients (n = 77, median age, 67 years; range, 31-94) had a median tumor size of 1.0 cm (range, 0.3-3.2). Mean follow-up (F/U) was 45 months (max. 153 months). Median tumor size did not change throughout F/U; there was no disease progression or disease specific mortality. In the operative group (n = 56, median age, 60 years; range, 27-82), median neoplasm size was 1.8 cm (range, 0.5-3.6). Mean F/U was 52 months (max. 138 months). A total of 46% of the operative patients had some type of complication, more than half due to a clinically significant pancreatic leak. No recurrence or disease specific mortality was seen in the operative group, including 5 patients with positive lymph nodes. Small nonfunctioning PNETs usually exhibit minimal or no growth over many years. Nonoperative management may be advocated when serial imaging demonstrates minimal or no growth without suspicious features. Copyright © 2012 Mosby, Inc. All rights reserved.
              • Record: found
              • Abstract: found
              • Article: not found

              Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States.

              Nonfunctional pancreatic neuroendocrine tumors (PNETs) ≤2 cm have uncertain malignant potential, and optimal treatment remains unclear. Objectives of this study were to better understand their malignant potential, determine whether extent of surgery or lymph node dissection is associated with overall survival (OS), and identify other factors associated with OS.

                Author and article information

                Journal
                Endocr Connect
                Endocr Connect
                EC
                Endocrine Connections
                Bioscientifica Ltd (Bristol )
                2049-3614
                November 2017
                25 October 2017
                : 6
                : 8
                : 876-885
                Affiliations
                [1 ]Institute of Liver Studies King’s College Hospital, London, UK
                [2 ]Department of Surgery and Cancer Imperial College, London, UK
                [3 ]Department of General Visceral and Thoracic Surgery, University Medical Center, Hamburg-Eppendorf, Hamburg, Germany
                [4 ]Department of Surgery King’s College Hospital, London, UK
                [5 ]Department of Histopathology King’s College Hospital, London, UK
                [6 ]Department of Surgery University Hospitals Coventry and Warwickshire, Coventry, UK
                [7 ]Department of Oncology University Hospital, Southampton, UK
                [8 ]Department of Surgery University Hospital, Southampton, UK
                [9 ]Department of Endocrinology University Hospitals Coventry and Warwickshire, Coventry, UK
                [10 ]Departments of Gastroenterology and Department of General Visceral and Thoracic Surgery, University Medical Center Hamburg-Eppendorf, Hamburg, Germany
                Author notes
                Correspondence should be addressed to R Srirajaskanthan; Email: r.srirajaskanthan@ 123456nhs.net
                Article
                EC170293
                10.1530/EC-17-0293
                5704448
                29150545
                1b270112-37b2-43c2-9e31-da04c02484e4
                © 2017 The authors

                This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

                History
                : 12 October 2017
                : 25 October 2017
                Categories
                Research

                neuroendocrinology,endocrine cancers,gastrointestinal tract,pancreas,surveillance

                Comments

                Comment on this article

                Related Documents Log